A series of 2-(p-substituted phenyl)-5-(2-{4-[(p-chloro-fluorophenyl)/phenyl] piperazin-1-yl}-acetamido)-benzoxazoles were synthesized and tested for their antimicrobial activities. The structures of the new derivatives were elucidated by spectral techniques. The minimum inhibitory concentrations (MIC) of the new benzoxazoles, along with those of previously synthesized analogues, were determined against standard bacterial and fungal strains and drug-resistant isolates, and compared with those of several reference drugs. The new benzoxazole derivatives were found to possess a broad spectrum of antimicrobial activity with MIC values of 32 -1024 µg/ml. Although the standard drugs were more active against the tested pathogens, the activities of the new benzoxazoles and the reference drugs were largely similar against the drug-resistant isolates.
Introduction
Microbial infectious diseases continue to be one of the leading causes of morbidity and mortality. It has been estimated that microbial species comprise about 60 % of the Earth's biomass. This, together with the fact that their genetic, metabolic, and physiological diversities are extraordinary, makes them a major threat to health across the world (Radulovic et al., 2013) . Antibiotics and antimicrobial agents are still the most potent weapons to fight bacterial infections, but the evolution of resistance has increasingly been becoming problematic both in hospitals and in agriculture (Betts et al., 2013) . Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VREF), and penicillin-resistant Streptococcus pneumoniae (PRSP) are important causes of morbidity and mortality today (Moustafa et al., 2004) . Besides, during the past 20 years an increase in invasive fungal infections, particularly in immunosuppressed patients, has been observed which are now considered to be the causes of morbidity and mortality as well. Thus, new drug classes are urgently needed (Chopra, 2013) .
Benzoxazoles, structural isosteres of natural nucleotides that can interact with biopolymers, constitute an important class of heterocyclic compounds with antimicrobial and antifungal activity (Prudhomme et al., 1986; Haansuu et al., 2001; Sarma et al., 2003; Temiz-Arpaci et al., 2002 , 2013 . Recently, we have described the synthesis of some 2-(p-substituted benzyl/phenyl)-5-[2-(4-substituted piperazin-1-yl)acetamido]-benzoxazoles and their in vitro antimicrobial activity against some Gram-positive and Gram-negative bacteria as well as the fungus Candida albicans (Temiz-Arpaci et al., 2005; Arisoy et al., 2008 Arisoy et al., , 2012 .
In this study, a new series of 2-(p-substituted phenyl) -5-(2-{4-[(p-chloro-fluorophenyl)/phenyl] piperazin-1-yl}acetamido)-benzoxazoles, 3 -17, has been synthesized using a three-step procedure as shown in Scheme 1. Synthesis of compounds 3 -17.
Scheme 1. In comparison with several control drugs and previously synthesized benzoxazole compounds with a homologous structure, the newly synthesized compounds were evaluated for their antibacterial and antifungal activities against standard strains and drug-resistant isolates.
Materials and Methods

Chemicals and analytical methods
Chemicals and solvents were purchased from Sigma-Aldrich (Munich, Germany) and Fisher Scientific (Pittsburgh, PA, USA), and used without further purification. Silica gel HF 254 chromatoplates (0.3 mm) were used for thin-layer chromatography, and chloroform was employed as mobile phase. Melting points were recorded on a Stuart Scientific SMP 1 instrument (Bibby Scientific Limited, Stone, Staffordshire, UK) and are uncorrected. NMR spectra were recorded on a Varian Mercury 400 MHz NMR spectrometer (Palo Alto, CA, USA) in CDCl 3 ; tetramethylsilane (TMS) was used as an internal standard. The mass spectra were recorded on a Waters ZQ Micromass LC-MS spectrometer (Milford, MA, USA) using the ESI(+) method. Elemental analyses were performed on an LECO 932 CHNS instrument (St. Joseph, MI, USA), and results were within ±0.4 % of theoretical values. 
Materials for microbiology
General procedure for the preparation of 5-amino-2-(p-substituted phenyl)-benzoxazoles 1a -1e
5 -Amino -2 -( p-substituted phenyl ) -benzoxazoles were synthesized by heating 0.02 mol 2,4-diaminophenol-hydrochloride with 0.02 mol p-substituted benzoic acid in 25 g polyphosphoric acid (PPA) and stirring for about 1 h at 160 -200 • C. At the end of the reaction period, the residue was poured over ice, and the solution was neutralized with 10 % NaOH. The resulting precipitate was filtered off, washed with distilled water, dissolved in boiling ethanol with 0.2 g charcoal, and again filtered off. Crystallization was achieved by dissolving the precipitate in ethanol and adding distilled water. The crude compounds 1a -1e were obtained by filtration and drying the filtrate under ambient conditions (Arisoy et al., 2008) .
General procedure for the preparation of 5-(2-chloroacetamido)-2-(p-substituted phenyl)-benzoxazoles 2a -2e
Chloroacetyl chloride (0.02 mol) was added over a period of 1 h to a stirred, ice-cooled mixture of a 5-amino-2-(p-substituted phenyl)-benzoxazole derivative (0.02 mol), sodium bicarbonate (0.02 mol), diethyl ether (40 ml), and water (20 ml). The mixture was stirred overnight. The precipitate formed was filtered off, washed with water, and dissolved in ethanol. Crystallization was done by adding distilled water, and the crude product was obtained by drying the filtrate under ambient conditions (Arisoy et al., 2008) .
General procedure for the preparation of 2-(p-substituted phenyl)-5-(2-{4-[(p-chloro-fluorophenyl)/phenyl]piperazin-1-yl}acetamido)-benzoxazoles 3 -17
0.002 mol 5-(2-chloroacetamido)-2-(p-substituted phenyl)-benzoxazole derivative was added to a mixture of 0.002 mol N- [(p-chloro-fluorophenyl) /phenyl] piperazine and 2 ml of triethylamine solution in 3 ml of N,N-dimethylformamide (DMF) and 2 ml of ethanol. The mixture was stirred at room temperature for 24 h. At the end of the reaction time, the mixture was poured over ice, an equal volume of 5 % (w/v) of aqueous NaOH solution was added, and the resulting mixture extracted with chloroform. The solvent was evaporated under reduced pressure, and the resulting crude product was purified by column chromatography using chloroform as mobile phase. Finally, the chloroform fractions were collected, the solvent evaporated, and crystallization was achieved by dissolving the residue in chloroform and adding petroleum ether. The crystalline material was dried in vacuo.
Microbiological assays
Stock solutions of the test compounds were prepared in DMSO. Bacterial susceptibility tests were performed according to the guidelines of CLSI M100-S18 (CLSI, 2008) . MHB was added to each well of the microplates. The bacterial suspensions used for inoculation were prepared at 10 6 CFU/ml by diluting fresh cultures at a McFarland density of 0.5. Suspensions of the bacteria at 10 6 CFU/ml were inoculated into the two-fold diluted solution of the respective test compound. A 10-µl bacterial inoculum was added to each well of the microplates. There were 10 5 CFU/ml bacteria in the wells after inoculation. Microplates were incubated at 37 • C overnight.
Fungal susceptibility tests were performed according to the guidelines of CLSI M27-A3 (CLSI, 2006) . RPMI-1640 medium with L-glutamine, buffered to pH 7 with MOPS, was added to each well of a microplate. The colonies were suspended in sterile saline, and the resulting suspension was adjusted to McFarland 0.5 density (10 6 CFU/ml). A working suspension was prepared by appropriate dilution of the stock suspension. Ten µl of this suspension were inoculated into the twofold diluted solution of the respective test compound resulting in 5 · 10 2 CFU/ml in the wells. Microplates were incubated at 35 • C for 24 -48 h.
After incubation, the lowest concentration of the compounds that completely inhibited macroscopic growth was determined and reported as minimum inhibitory concentration (MIC). All solvents, pure microorganisms, and pure media were used in control wells. All experiments were done in three parallel series.
Results and Discussion
In the present investigation, a new series of 2-(psubstituted phenyl)-5-(2-{4-[(p-chloro-fluorophenyl)/ phenyl]piperazin-1-yl}acetamido)-benzoxazoles were synthesized. Their structures were elucidated by mass and 1 H NMR spectroscopy, and their purity was controlled through elemental analysis (Table I ). All newly H 4.72, N 11.40/ C 61.03, H 4.63, N 11.36 synthesized compounds 3 -17 were evaluated for their antimicrobial activity in comparison with standard drugs and previously synthesized benzoxazole having homologous structures and the results are presented in Table II . Compounds 3 -17 exhibited broad antibacterial activity with MIC values of 128 -256 µg/ml against S. aureus and the MRSA isolate, and derivative 9 had a MIC value of 64 µg/ml. All derivatives had lower antibacterial activity against the standard strain of this pathogen, whereas they possessed the same or similar MIC values as ampicillin (64 µg/ml) and gentamicin (32 µg/ml) against its drug-resistant isolate, MRSA. The previously synthesized benzoxazole derivatives 18 -27 were more potent than those synthesized in this study. The newly synthesized compounds exhibited antibacterial activities with MIC values between 32 and 512 µ g/ml against E. faecalis and the VRE isolate. The activities of the new benzoxazoles were similar to those of the previously synthesized derivatives. Among the new compounds, 3, 5, and 12 -14 were found as the most potent derivatives with a MIC value of 32 µg/ml against the vancomycin-resistant isolate of E. faecalis, having the same potency as the standard drugs gentamicin and vancomycin. All newly synthesized benzoxazole derivatives exhibited antibacterial activity against the Gram-negative bacteria E. coli and P. aeruginosa and their respective drug-resistant isolates, with MIC values between 32 and 512 µg/ml, except for derivative 17, which was the least effective compound against gentamicin-resistant P. aeruginosa with a MIC value of 1024 µg/ml. On the other hand, many of the new compounds, 3, 5, 6, 12 -14, possessed higher activity than the previously synthesized 
